Thank you for visiting Astra Logics Investor Relations page. We appreciate your interest in our company.
Astra Logics is a start-up biotech company whose broad objective is firmly focused on developing improved cancer treatments that accelerate the eradication of tumors, while having the least side effects. To this end, we have developed molecular diagnostic and drug delivery systems aimed specifically to treat cancer by using Graphene Oxide as a nano-carrier for the controlled loading and targeted delivery of anti-cancer drugs.
In addition, the company is currently collaborating with several pharmaceutical companies in with a view to the development of companion diagnostic tests for various other cancer therapies, helping us to one day realize the promise of precision oncology.
We welcome inquiries from institutional investors, financial analysts and private individuals. For more information, please contact our International Investor Relations team at: